Paul E Greene, MD Email Paul Greene
- ASSOCIATE PROFESSOR | Neurology
- Hospital Affiliation
- The Mount Sinai Hospital
- Bendheim Movement Disorder Center 212-241-5607212-241-5607
Neurology, American Board of Psychiatry and Neurology
- Botulinum Toxin Injections
- Cervical Dystonia
- Essential Tremor
- Focal Dystonia
- Hemifacial Spasm
- Huntington's Disease
- Lewy Body Disease
- Multiple System Atrophy
- Parkinson's Disease
- Shy-Drager Syndrome
- Tardive Dyskinesia
- Tourette Syndrome
- Wilson's Disease
MD, University of Connecticut
Internship, Internal Medicine
Bronx-Lebanon Hospital (Fulton Div)/Albert Einstein College of Med
Albert Einstein College of Medicine
Fellowship, Movement Disorder
Columbia University Medical Center
Kuncel AM, Turner DA, Ozelius LJ, Greene PE, Grill WM, Stacy MA. Myoclonus and tremor response to thalamic deep brain stimulation parameters in a patient with inherited myoclonus-dystonia syndrome. Clinical neurology and neurosurgery 2009 Apr; 111(3).
Leonardos A, Greene PE, Weimer LH, Khandji AG, Mazzoni P. Hemifacial spasm associated with intraparenchymal brain stem tumor. Movement disorders : official journal of the Movement Disorder Society 2011 Nov; 26(13).
Virmani T, Thenganatt MA, Goldman JS, Kubisch C, Greene PE, Alcalay RN. Oculogyric crises induced by levodopa in PLA2G6 parkinsonism-dystonia. Parkinsonism & related disorders 2014 Feb; 20(2).
Virmani T, Greene PE, Pearson TS. Delayed onset of progressive chorea after acute basal ganglia injury. Movement disorders : official journal of the Movement Disorder Society 2013 May; 28(5).
Thenganatt MA, Alcalay RN, Vonsattel JP, Greene PE. Somatic mitochondrial DNA mutations and parkinsonism. Annals of neurology 2012 Nov; 72(5).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Greene did not report having any of the following types of financial relationships with industry during 2018 and/or 2019: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.